{"id":"W4401875916","doi":"10.1016/s2152-2650(24)01666-5","title":"MM-336 Long-Term Follow-Up From the Phase 1/2 MajesTEC-1 Trial of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Refractory (planetary science); Multiple myeloma; Internal medicine; Oncology; Term (time); Nuclear medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002056865,0.0007452875,0.002043298,0.0003490451,0.0007330253,0.001305006,0.000607717,0.001091425,0.004339542],"category_scores_gemma":[0.0015417,0.0003361495,0.002269329,0.0005008808,0.0003926553,0.0009139904,0.0005395171,0.002814899,0.001011163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009865683,"about_ca_system_score_gemma":0.0009653625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001682748,"about_ca_topic_score_gemma":0.005125929,"domain_scores_codex":[0.9992849,0.0002896721,0.00004172891,0.0001107326,0.0000847116,0.0001883193],"domain_scores_gemma":[0.9989251,0.0001756746,0.000265734,0.0001232522,0.00009336755,0.0004167498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.730111,0.005730597,0.06330894,0.001001339,0.006420749,0.0006588709,0.0002252506,0.003292098,0.01213082,0.00044291,0.02322121,0.1534563],"study_design_scores_gemma":[0.3402991,0.1608721,0.4447683,0.0004695082,0.009963172,0.001478783,0.000237458,0.002354437,0.004293976,0.001861642,0.03326491,0.000136591],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9671458,0.0115164,0.000697505,0.002607762,0.0003657834,0.0006126377,0.01222487,0.000121679,0.004707566],"genre_scores_gemma":[0.9660244,0.002773312,0.0008139772,0.002810086,0.0004095498,0.0005869829,0.02203557,0.00003540638,0.004510822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004339542,"threshold_uncertainty_score":0.01451725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03879234626957807,"score_gpt":0.3476872003197711,"score_spread":0.3088948540501931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}